Peak Financial Advisors LLC Abb Vie Inc. Transaction History

Peak Financial Advisors LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 10, 2024	BUY	$137.6 - $154.97 $2.26 Million - $2.55 Million	16,460 New	16,460 $2.55 Million
Q4 2022 Jan 12, 2023	SELL	$138.31 - $165.87 $132,086 - $158,405	-955 Reduced 34.36%	1,824 $295 Million
Q3 2022 Oct 26, 2022	BUY	$134.21 - $153.93 $18,252 - $20,934	136 Added 5.15%	2,779 $373,000
Q2 2022 Jul 14, 2022	BUY	$137.62 - $174.96 $22,432 - $28,518	163 Added 6.57%	2,643 $405,000
Q1 2022 Apr 22, 2022	BUY	$131.98 - $163.75 $327,310 - $406,100	2,480 New	2,480 $402,000
Q3 2021 Oct 12, 2021	SELL	$106.4 - $120.78 $550,939 - $625,398	-5,178 Closed	0 $0
Q2 2021 Jul 26, 2021	BUY	$105.21 - $117.21 $25,671 - $28,599	244 Added 4.95%	5,178 $583,000
Q1 2021 May 11, 2021	SELL	$102.3 - $112.62 $22,301 - $24,551	-218 Reduced 4.23%	4,934 $534,000
Q4 2020 Feb 02, 2021	BUY	$80.49 - $108.67 $414,684 - $559,867	5,152 New	5,152 $552,000

3,943

1.26B

16.8M

12.1M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $337B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Peak Financial Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Peak Financial Advisors LLC with notifications on news.